ADVERTISEMENT
ADVERTISEMENT
Image of a white cardboard box with a blue vertical stripe on the left side, the word “Apixaban” in blue lettering at the bottom, and a depiction of apixaban’s molecular structure in black.
Blood Thinner Ineffective for COVID-19 Patients: Study
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
Blood Thinner Ineffective for COVID-19 Patients: Study
Blood Thinner Ineffective for COVID-19 Patients: Study

A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.

A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.

anticoagulant
Graphene Coating Cleans Up Clots
Kerry Grens | Feb 12, 2014 | 1 min read
Blood clots on medical devices might be reduced by a graphene-based material.  
Pharmacogenetics Puzzle
Tracy Vence | Nov 20, 2013 | 2 min read
Conflicting clinical trial results leave researchers unsure whether genetic information is useful for determining initial Warfarin dosage.
Bad Blood
Kerry Grens | Nov 1, 2013 | 4 min read
A rare bleeding disorder leads scientists to uncover an unusual blood component that might be common to us all.
ADVERTISEMENT